H.R. 2891 · 117th Congress

Preserve Access to Affordable Generics and Biosimilars Act

Stage
Reported from committee
Sponsor
Jerrold Nadler
Introduced
2021-04-28
Latest action
2021-09-29 · Committee Consideration and Mark-up Session Held.

Subjects

Administrative law and regulatory procedures
Health
Civil actions and liability
Licensing and registrations
Intellectual property
Prescription drugs
Marketing and advertising
Competition and antitrust
Manufacturing
Judicial review and appeals
Contracts and agency
Federal Trade Commission (FTC)